MedTrace Logo

Treatment of Patients With Major Depressive Disorder With MK0869 (0869-062)(COMPLETED)

NCT00048607 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2017-05-05

No results posted yet for this study

Summary

A clinical study to determine the efficacy and safety of MK0869 in the treatment of depression

Conditions

Interventions

DRUG

aprepitant

DRUG

Comparator: paroxetine HCL

DRUG

Comparator: Placebo (Unspecified)

Sponsors & Collaborators

Principal Investigators

  • Medical Monitor · Merck Sharp & Dohme LLC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-07-30
Primary Completion
2003-12-31
Completion
2003-12-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00048607 on ClinicalTrials.gov